These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 14895381)
1. [Frequency of toxic jaundice due to phenylcinchoninic acid (atophan, cinchophen)-preventive measures]. VARELA FUENTES B; MARTINEZ PRADO G; GOMED DEL VALLE C Arch Urug Med Cir Espec; 1951; 38(5-6):351-60. PubMed ID: 14895381 [No Abstract] [Full Text] [Related]
2. [Two new observations concerning icterus caused by atophan]. LEVRAT M; ROCHE L; BRETTE R; LEHMANN M; KALB JC Lyon Med; 1953 Mar; 188(9):185-90. PubMed ID: 13062720 [No Abstract] [Full Text] [Related]
3. [Two cases of acute parenchymatous jaundice following atophan therapy]. KOSINSKI W; MIARCZYNSKA J Pol Tyg Lek (Wars); 1951 Sep; 6(38):1228-30. PubMed ID: 14891431 [No Abstract] [Full Text] [Related]
4. [Acute yellow atrophy of the liver due to phenylcinchoninic acid]. BARBERA L Policlinico Prat; 1952 Feb; 59(6):169-76. PubMed ID: 14920280 [No Abstract] [Full Text] [Related]
5. [Jaundice caused by cinchophen]. BRETTE R; CERF R; LEVRAT M Rev Int Hepatol; 1956; 6(3):295-309. PubMed ID: 13359882 [No Abstract] [Full Text] [Related]
6. [Comparative toxicity of phenylcinchoninic acid, alkylthienylcinchoninic acids and their sodium salt]. QUEVAUVILLER A C R Seances Soc Biol Fil; 1945; 139(11-12):523-5. PubMed ID: 21020688 [No Abstract] [Full Text] [Related]
11. [Synthesis of 2-phenylquinolin-4-carboxylic acid or atophan]. ALVAREZ RADA E Rev Univ San Marcos Fac Farm Bioquim; 1948; 10(39-40):188-99. PubMed ID: 18125712 [No Abstract] [Full Text] [Related]
12. [Acute aplastic anemia following atophan medication]. WISING P Sven Lakartidn; 1953 Sep; 50(37):1913-6. PubMed ID: 13102271 [No Abstract] [Full Text] [Related]
14. [Phenolic metabolites of cinchophen (Atophan) in urine]. Sípal Z; Jindra A Pharmazie; 1965 Jun; 20(6):376-8. PubMed ID: 4379543 [No Abstract] [Full Text] [Related]
15. Certain aspects of the pharmacology of 3-hydroxy-2-phenylcinchoninic acid. MARSHALL EK; DEARBORN EH Bull Johns Hopkins Hosp; 1950 Jul; 87(1):36-49. PubMed ID: 15426851 [No Abstract] [Full Text] [Related]
16. The effect of 3-hydroxy-2-phenylcinchoninic acid upon rheumatic fever. BLANCHARD KC; HARVEY AM; HOWARD JE; KATTUS A; MARSHALL EK; NEWMAN EV; ZUBROD CG Bull Johns Hopkins Hosp; 1950 Jul; 87(1):50-60. PubMed ID: 15426852 [No Abstract] [Full Text] [Related]
17. Effect of vagus exclusion on the atophan (cinchophen) ulcer of dogs. HAMORI A; SCOSSA K; HETENYI G Acta Med Acad Sci Hung; 1950; 1(1):120-36. PubMed ID: 14782850 [No Abstract] [Full Text] [Related]
18. Acute yellow atrophy following cinchophen administration; report of a case. LENZNER AR; LOCKIE LM; BECKER CF N Engl J Med; 1947 Apr; 236(14):500-4. PubMed ID: 20291578 [No Abstract] [Full Text] [Related]
19. On the toxicity of 3-hydroxy-2-phenylcinchoninic acid (oxycinchophen); histo-pathological studies in rabbits and guinea-pigs. IVERSEN M; MUNCK J; SCHOURUP K Acta Pharmacol Toxicol (Copenh); 1953; 9(3):215-9. PubMed ID: 13123940 [No Abstract] [Full Text] [Related]
20. [Relation between the chemical structure, antipyretic effect and toxicity of some cinchophen analogues]. Medvecký R; Durinda J; Zácková P; Kopácová L Cesk Farm; 1966 Jul; 15(6):291-3. PubMed ID: 4380621 [No Abstract] [Full Text] [Related] [Next] [New Search]